Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiro Aoki

Showing results (31-40 of 140) with videos related to

Pageof 14
Sort By:
Kidney International|December 22, 2004
Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patientsJiro Aoki, Yuji Ikari, Hiroyoshi Nakajima, et al.
International Journal of Cardiology|October 11, 2024
Glucagon-like peptide-1 receptor agonists improve outcomes in individuals with type 2 diabetes with and without heart failureYu Horiuchi, Nicholas Wettersten, Masahiko Asami, et al.
Journal of the American College of Cardiology|November 1, 2005
Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patientsJiro Aoki, Alexandre C Abizaid, Patrick W Serruys, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 30, 2016
Three-Year Clinical Outcomes of Everolimus-Eluting Stents From the Post-Marketing Surveillance Study of Cobalt-Chromium Everolimus-Eluting Stent (XIENCE V/PROMUS) in JapanJiro Aoki, Ken Kozuma, Masaki Awata, et al.
Cardiovascular Intervention and Therapeutics|July 21, 2017
The impact of coronary calcification on angiographic and 3-year clinical outcomes of everolimus-eluting stents: results of a XIENCE V/PROMUS post-marketing surveillance studyNobuo Shiode, Ken Kozuma, Jiro Aoki, et al.
Cardiovascular Intervention and Therapeutics|February 28, 2018
Five-year clinical outcomes of everolimus-eluting stents from the post marketing study of CoCr-EES (XIENCE V/PROMUS) in JapanJiro Aoki, Ken Kozuma, Masaki Awata, et al.
Cardiovascular Intervention and Therapeutics|October 9, 2015
Feasibility of 320-row multi-detector computed tomography angiography to assess bioabsorbable everolimus-eluting vascular scaffoldsMasahiko Asami, Jiro Aoki, Patrick W Serruys, et al.
International Heart Journal|March 22, 2017
Effects of Long-Acting Loop Diuretics in Heart Failure With Reduced Ejection Fraction Patients With Cardiac Resynchronization TherapyMasahiko Asami, Jiro Aoki, Shuzou Tanimoto, et al.
Cureus|May 29, 2024
Valuable Predictors for Non-measurability of Fractional Flow Reserve Derived From Coronary Computed Tomography AngiographyHideaki Nonaka, Kazuyuki Yahagi, Kota Komiyama, et al.
International Heart Journal|October 3, 2017
Association of Dyslipidemia and Sex With Coronary Artery Calcium Assessed by Coronary Computed Tomography AngiographyMasahiko Asami, Kyohei Yamaji, Jiro Aoki, et al.
Pageof 14

Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
Kidney International|December 22, 2004
Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patientsJiro Aoki, Yuji Ikari, Hiroyoshi Nakajima, et al.
International Journal of Cardiology|October 11, 2024
Glucagon-like peptide-1 receptor agonists improve outcomes in individuals with type 2 diabetes with and without heart failureYu Horiuchi, Nicholas Wettersten, Masahiko Asami, et al.
Journal of the American College of Cardiology|November 1, 2005
Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patientsJiro Aoki, Alexandre C Abizaid, Patrick W Serruys, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 30, 2016
Three-Year Clinical Outcomes of Everolimus-Eluting Stents From the Post-Marketing Surveillance Study of Cobalt-Chromium Everolimus-Eluting Stent (XIENCE V/PROMUS) in JapanJiro Aoki, Ken Kozuma, Masaki Awata, et al.
Cardiovascular Intervention and Therapeutics|July 21, 2017
The impact of coronary calcification on angiographic and 3-year clinical outcomes of everolimus-eluting stents: results of a XIENCE V/PROMUS post-marketing surveillance studyNobuo Shiode, Ken Kozuma, Jiro Aoki, et al.
Cardiovascular Intervention and Therapeutics|February 28, 2018
Five-year clinical outcomes of everolimus-eluting stents from the post marketing study of CoCr-EES (XIENCE V/PROMUS) in JapanJiro Aoki, Ken Kozuma, Masaki Awata, et al.
Cardiovascular Intervention and Therapeutics|October 9, 2015
Feasibility of 320-row multi-detector computed tomography angiography to assess bioabsorbable everolimus-eluting vascular scaffoldsMasahiko Asami, Jiro Aoki, Patrick W Serruys, et al.
International Heart Journal|March 22, 2017
Effects of Long-Acting Loop Diuretics in Heart Failure With Reduced Ejection Fraction Patients With Cardiac Resynchronization TherapyMasahiko Asami, Jiro Aoki, Shuzou Tanimoto, et al.
Cureus|May 29, 2024
Valuable Predictors for Non-measurability of Fractional Flow Reserve Derived From Coronary Computed Tomography AngiographyHideaki Nonaka, Kazuyuki Yahagi, Kota Komiyama, et al.
International Heart Journal|October 3, 2017
Association of Dyslipidemia and Sex With Coronary Artery Calcium Assessed by Coronary Computed Tomography AngiographyMasahiko Asami, Kyohei Yamaji, Jiro Aoki, et al.
Pageof 14